| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 04/18/2012 | EP1499358B1 Ph-sensitive polymer |
| 04/18/2012 | EP1284724B1 Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
| 04/18/2012 | EP1207876B9 Use of a modulator which acts on a growth factor precursor in order to inhibit growth factor precursor processing |
| 04/18/2012 | CN1813699B Medicinal composition |
| 04/18/2012 | CN102421450A 治疗虚弱的方法 Method of treating weak |
| 04/18/2012 | CN102421425A Phosphate-free pharmaceutical composition for the treatment of glaucoma |
| 04/18/2012 | CN102417923A 与慢性乙型肝炎中医肝胆湿热证相关的基因序列的应用 TCM with chronic hepatitis and gallbladder damp-heat syndrome gene sequences related applications |
| 04/18/2012 | CN102416226A 用于治疗皮肤病学状况的装置 Apparatus for the treatment of dermatological condition |
| 04/18/2012 | CN102416179A Inhaled compound composition for asthma |
| 04/18/2012 | CN102415986A 含磷脂和胆盐的难溶性药物固体分散体及其制备方法 Phospholipid containing a poorly soluble drug and bile solids dispersion and its preparation method |
| 04/18/2012 | CN102091134B 一种抗抗菌素多重耐药的中药组合物 An anti-antibiotic medicine composition for multi-drug resistant |
| 04/18/2012 | CN102038955B 利用傅氏反应接枝制备抗凝血聚砜材料的方法 Friedel-Crafts-grafted use anticoagulant polysulfone material preparation methods |
| 04/18/2012 | CN101757624B 一种预防和治疗老年痴呆症的组合物 A method of preventing and treating Alzheimer's composition |
| 04/18/2012 | CN101721389B 一种原位载治疗性物质微胶囊的制备方法 An in-situ treatment of substances contained in the preparation of microcapsules |
| 04/17/2012 | US8158768 Immunostimulatory sequence oligonucleotides and methods of using the same |
| 04/17/2012 | US8158752 Therapeutic agent and therapeutic method for periodontal diseases and pulpal diseases |
| 04/17/2012 | US8158669 Method for treating neovascularization |
| 04/17/2012 | US8158613 Topical pharmaceutical formulations and methods of treatment |
| 04/17/2012 | US8158606 β-L-2′-deoxynucleosides for the treatment of resistant HBV strains and combination therapies |
| 04/17/2012 | US8158604 2-propynyl adenosine analogs having A2A agonist activity and compositions thereof |
| 04/17/2012 | US8158592 for treatment of atopic conditions (dermatitis, allergies); point mutations; immunotherapy |
| 04/17/2012 | US8158585 Controlling extracellular protein degradation and/or clearance via modulation of tissue plasminogen activator activity; treating diabetic, autoimmune, cardiovascular, blood and nervous system disorders |
| 04/17/2012 | US8158578 Methods for treating neurological deficits |
| 04/17/2012 | US8158133 Pharmaceutical composition useful for vaccines |
| 04/17/2012 | CA2660151C Compositions and methods for treating, controlling, reducing, or ameliorating infections and sequelae thereof |
| 04/17/2012 | CA2555759C Hyaluronic acid derivative and drug containing the same |
| 04/17/2012 | CA2552607C Cosmetic composition and method for retarding hair growth |
| 04/17/2012 | CA2543659C Useful immunotherapeutic agent for the combined treatment of tuberculosis in association with other drugs |
| 04/17/2012 | CA2542854C Graduated estrogen contraceptive |
| 04/17/2012 | CA2529351C Use of prostaglandin i for enhancing the effect of a renin-angiotensin system inhibitor on a renal disease |
| 04/17/2012 | CA2528710C A method of treating an anxiety disorder |
| 04/17/2012 | CA2517429C Process for manufacturing a pharmaceutical composition in the form of tablets containing a fibrate and the tablets obtained through the process |
| 04/17/2012 | CA2516327C Therapeutic system comprising amoxicillin and clavulanic acid |
| 04/17/2012 | CA2488120C Pharmaceutical composition for improving cerebral function and method for improving cerebral function |
| 04/17/2012 | CA2483826C Epothilone derivative for the treatment of hepatoma and other cancer diseases |
| 04/17/2012 | CA2450007C Compounds and methods for the treatment or prevention of flavivirus infections |
| 04/17/2012 | CA2427844C Naphthalene derivatives |
| 04/17/2012 | CA2410526C Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds |
| 04/17/2012 | CA2402894C Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase iv and method |
| 04/17/2012 | CA2377607C Neurotrophic factor receptor |
| 04/17/2012 | CA2363958C Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction |
| 04/17/2012 | CA2347928C Cell surface molecule-induced macrophage activation |
| 04/12/2012 | WO2012048235A1 Vitamin e formulations of sulfamide ns3 inhibitors |
| 04/12/2012 | WO2012047871A1 Polymorphs of saxagliptin hydrochloride and processes for preparing them |
| 04/12/2012 | WO2012046874A1 Method for evaluating degree of cancerization |
| 04/12/2012 | WO2012046873A1 Method for evaluating degree of cancerization |
| 04/12/2012 | WO2012046872A1 Method for evaluating degree of cancerization |
| 04/12/2012 | WO2012046871A1 Method for evaluating degree of cancerization |
| 04/12/2012 | WO2012046797A1 Cancer stem cell mass and process for production thereof |
| 04/12/2012 | WO2012045704A1 New treatments of hepatitis c virus infection |
| 04/12/2012 | WO2012045285A1 Pharmaceutical composition and application thereof |
| 04/12/2012 | WO2012045210A1 Pharmaceutical composition for treating septic shock and its use |
| 04/12/2012 | WO2012020123A3 Neuropilin as a biomarker for bevacizumab combination therapies |
| 04/12/2012 | WO2012015998A3 Preservative free bimatoprost and timolol solutions |
| 04/12/2012 | WO2012007846A3 A combination pharmaceutical composition and methods of treating diseases or conditions associated with the cardiovascular system |
| 04/12/2012 | WO2011124953A3 Controlled release pharmaceutical compositions of tapentadol |
| 04/12/2012 | WO2011077245A3 Composition comprising an oxysterol modulator and a cd25 - depleting monoclonal antibody for treating cancer |
| 04/12/2012 | US20120088778 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents |
| 04/12/2012 | US20120088777 5-ht1a receptor subtype agonist |
| 04/12/2012 | US20120088743 Combinations comprising antimuscarinic agents and pde4 inhibitors |
| 04/12/2012 | US20120088297 Mycobacterial antigens expressed under low oxygen tension |
| 04/12/2012 | US20120088264 Methods for determining efficacy of chemotherapeutic agents |
| 04/12/2012 | US20120087994 Systemic administration of nac as an adjunct in the treatment of bioterror exposures such as smallpox and use in combination with dhea for the treatment of smallpox |
| 04/12/2012 | US20120087923 Antibodies to OPGL |
| 04/12/2012 | DE102011077065A1 Use of glucosidase inhibitors for producing topically applicable agents for prophylaxis of retroviral infections |
| 04/12/2012 | CA2811799A1 Vitamin e formulations of sulfamide ns3 inhibitors |
| 04/12/2012 | CA2811700A1 New treatments of hepatitis c virus infection |
| 04/11/2012 | EP2438927A1 Pharmaceutical composition, food or beverage, and methods for these products |
| 04/11/2012 | EP2438917A1 Transdermal preparation |
| 04/11/2012 | EP2438913A1 A non-selective cation channel in neural cells and compounds that block the channel for use in treating brain swelling |
| 04/11/2012 | EP2437774A1 Diagnosis of restenosis in patients undergoing percutaneous coronary intervention |
| 04/11/2012 | EP2437748A1 Combination preparations comprising a cytokine antagonist and corticosteroid |
| 04/11/2012 | EP2437747A1 Combination preparations comprising exosomes and corticosteroid |
| 04/11/2012 | EP2437745A1 Treatment of mammalian disorders mediated by alpha-carbonic anhydrase isoforms |
| 04/11/2012 | EP2437742A1 New compositions for treating cmt and related disorders |
| 04/11/2012 | EP2437741A1 The use of amlexanox in the therapy of neutrophil-driven diseases |
| 04/11/2012 | EP2437737A1 Composition including at least one trans-cinnamaldehyde and the use thereof in the treatment of bacterial infections, specifically in the treatment of nosocomial infections |
| 04/11/2012 | EP2437732A1 Combination of dopamine agonists plus first phase insulin secretagouges for the treatment of metabolic disorders |
| 04/11/2012 | EP2437729A2 Tamper resistant dosage form comprising a matrix and melt-extruded particulates comprising a drug |
| 04/11/2012 | EP2081599B1 Compounds, kits and methods for conferring cytoprotection |
| 04/11/2012 | EP1970075B1 THERAPEUTIC AGENT FOR NEUROBLASTOMA TARGETING ARID3b |
| 04/11/2012 | EP1753860B1 Intervertebral disc repair and methods therefor |
| 04/11/2012 | EP1532153B8 Azepinoindole and pyridoindole derivatives as pharmaceutical agents |
| 04/11/2012 | EP1463528B1 Selective norepinephrine serotonin reuptake inhibitors for treating fibromyalgia syndrome, chronic fatique syndrome and pain |
| 04/11/2012 | EP1377596B1 Ttk in diagnosis and as a therapeutic target in cancer |
| 04/11/2012 | EP1326840B1 Substituted heterocyclic compounds for treating multidrug resistance |
| 04/11/2012 | CN202184953U 载抗肿瘤药物术后防粘连膜 Upload anticancer drugs after anti-adhesion film |
| 04/11/2012 | CN102413841A 鱼类寄生虫驱除方法 Fish antiparasitic method |
| 04/11/2012 | CN102413840A Agent for regulating composition ratio of intestinal bacterial flora |
| 04/11/2012 | CN102413824A 对皮肤有益的口服组合物 Beneficial to the skin of an oral composition |
| 04/11/2012 | CN102413822A 提高哺乳动物中内源性缩醛磷脂水平的方法 Improved mammalian endogenous level of a plasmalogen |
| 04/11/2012 | CN102413821A 经皮吸收型制剂 Percutaneous absorption type preparation |
| 04/11/2012 | CN102408469A Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 04/11/2012 | CN102406940A Application of nanoscale flaky carboxymethyl starch sodium in solid sipersion |
| 04/11/2012 | CN102406938A 一种抗血栓的药物组合物 Antithrombotic pharmaceutical composition |
| 04/11/2012 | CN102406671A Application of Chinese herbal medicine Folium llicis Latifoliae extract in preparation of weight-losing and fat-reducing medicine or preparation of medicine with lipase activity inhibition function |
| 04/11/2012 | CN102406642A Compositions of non-steroidal anti-inflammatory drugs decongestants and anti-histamines |
| 04/11/2012 | CN102406595A Floating bioadhesive porous hydrogel and preparation method thereof |
| 04/11/2012 | CN101816791B 一种含头孢美唑和β-内酰胺酶抑制剂的药物组合物 Containing cefmetazole and β- lactamase inhibitor pharmaceutical composition |
| 04/10/2012 | US8153768 Complex of antibodic and antibiotic with carrier |